X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Torrent Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-16
TEVA PHARMA
Dec-13
TORRENT PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,7202,678-   
Low Rs1,1342,326-   
Sales per share (Unadj.) Rs394.51,537.0-  
Earnings per share (Unadj.) Rs101.896.0-  
Cash flow per share (Unadj.) Rs116.3220.2-  
Dividends per share (Unadj.) Rs40.0084.05-  
Dividend yield (eoy) %2.83.4 83.5%  
Book value per share (Unadj.) Rs200.31,707.3-  
Shares outstanding (eoy) m169.22848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.61.6 222.1%   
Avg P/E ratio x14.026.1 53.8%  
P/CF ratio (eoy) x12.311.4 108.0%  
Price / Book Value ratio x7.11.5 486.1%  
Dividend payout %39.387.5 44.9%   
Avg Mkt Cap Rs m241,4352,121,900 11.4%   
No. of employees `00010.944.9 24.2%   
Total wages/salary Rs m8,5590-   
Avg. sales/employee Rs Th6,129.628,998.7 21.1%   
Avg. wages/employee Rs Th785.80-   
Avg. net profit/employee Rs Th1,581.31,811.5 87.3%   
INCOME DATA
Net Sales Rs m66,7641,303,346 5.1%  
Other income Rs m2,1560-   
Total revenues Rs m68,9201,303,346 5.3%   
Gross profit Rs m27,204356,922 7.6%  
Depreciation Rs m2,461105,351 2.3%   
Interest Rs m1,85925,600 7.3%   
Profit before tax Rs m25,041225,972 11.1%   
Minority Interest Rs m01,027 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-1,403-148,338 0.9%   
Tax Rs m6,414-2,759 -232.5%   
Profit after tax Rs m17,22481,419 21.2%  
Gross profit margin %40.727.4 148.8%  
Effective tax rate %25.6-1.2 -2,097.9%   
Net profit margin %25.86.2 413.0%  
BALANCE SHEET DATA
Current assets Rs m46,622880,275 5.3%   
Current liabilities Rs m32,843767,674 4.3%   
Net working cap to sales %20.68.6 238.9%  
Current ratio x1.41.1 123.8%  
Inventory Days Days7491 81.8%  
Debtors Days Days7996 82.4%  
Net fixed assets Rs m39,029425,702 9.2%   
Share capital Rs m8463,208 26.4%   
"Free" reserves Rs m31,4000-   
Net worth Rs m33,8901,447,770 2.3%   
Long term debt Rs m18,637666,430 2.8%   
Total assets Rs m90,1362,978,564 3.0%  
Interest coverage x14.59.8 147.3%   
Debt to equity ratio x0.50.5 119.5%  
Sales to assets ratio x0.70.4 169.3%   
Return on assets %21.23.6 589.2%  
Return on equity %50.85.6 903.7%  
Return on capital %48.54.9 984.3%  
Exports to sales %43.30-   
Imports to sales %6.90-   
Net fx Rs m23,1650-   
CASH FLOW
From Operations Rs m27,132207,686 13.1%  
From Investments Rs m-7,014-73,592 9.5%  
From Financial Activity Rs m-14,352-249,133 5.8%  
Net Cashflow Rs m5,767-115,039 -5.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.16 Rs / USD

Compare TORRENT PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare TORRENT PHARMA With: SUN PHARMA  NOVARTIS  IPCA LABS  PLETHICO PHARMA  VENUS REMEDIES  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Aug 21, 2017 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 5-YR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS